Association for Molecular Pathology                       
Newsletter                                                                
   
May 2009, Volume 15, Number 2 

Inside this Issue

Front Page
President's Message
Committee Reports
• Clinical Practice Committee
• Economic Affairs Committee
• Membership & Professional
  Development Committee

• Nominating Committee
• Professional Relations Committee
• Program Committee
• Publications Committee
• Training & Education Committee
Subdivision Reports
• Genetics
• Hematopathology
• Infectious Diseases
• Solid Tumors
Special Features
• AMP Leadership Award
• CHAMP

• Member Survey Report
• Web Editorial Board Report
• Show Me the Money!
• Announcements
• Career Opportunities
• Meetings and Upcoming Events
2009 AMP Officers and Appointees

Infectious Diseases Subdivision Report

Frederick S. Nolte, PhD, D(ABMM), F(AAM) By Frederick S. Nolte, PhD, D(ABMM), F(AAM)
Chair, Infectious Diseases Subdivision
e-mail: nolte@musc.edu

I am pleased to report that after countless e-mails and teleconferences the Infectious Diseases portion of the Program for the 2009 Annual Meeting is finally set.  Our Plenary Session is titled “Mass Spectrometry for Identification and Characterization of Microorganisms” and will be comprised of three presentations.  Dave Ecker, of Ibis Biosciences, will provide a brief overview of the principles of mass spectrometry and the available instrument platforms.  Charlotte Gaydos, of Johns Hopkins University, will discuss the use of mass spectrometry for direct detection and identification of respiratory viruses in clinical specimens.  Donna Wolk, of the University of Arizona, will wind up the session with a talk on the application of this technology for genetic profiling of bacteria.   Special thanks to Donna for her efforts in making this exciting session a reality. 

We will also hold two Workshops at the Meeting.   The first Workshop will be focused on new strategies for the diagnosis and management of Clostridium difficile-associated disease.  Dale Gerding, of Loyola University, Chicago Stritch School of Medicine, has agreed to talk about disease spectrum, outcomes, epidemiology, surveillance and prevention.   Karen Carroll, of Johns Hopkins University, will discuss the available laboratory diagnostic methods and algorithms, with particular emphasis on the role of molecular methods for detection of toxigenic strains.  We are fortunate to have speakers of their stature and experience as part of this Workshop. 

The Infectious Diseases Subdivision decided to devote the second Workshop to platform presentations of selected abstracts.  This gives us an opportunity to provide special recognition to those authors of abstracts of particular importance or interest to the Subdivision, and provides a forum to more broadly discuss the findings.   A multidisciplinary Plenary Session that I am sure will be of interest to the members of the Infectious Diseases Subdivision is titled “Molecular Testing in the Developing World”.   Stay tuned for more details on this session.  

I am also pleased to point out that the results of the CMV Working Group were recently published in JMD (March, 2009).  This group was formed in the Fall of 2003 under the leadership of Daynna Wolff, my colleague here at Medical University of South Carolina, and with the help of Paul Neuwald of AcroMetrix, a multi-center assessment of CMV viral load assays was conducted in 2004.  The study demonstrated that laboratories across the country using a variety of different assays and platforms performed similarly in terms of relative quantitation but there was disparity in terms of the absolute values assigned to samples.  The current focus of this group is to work with the National Institutes of Standards and Technologies (NIST) to develop standard reference material for nucleic acid amplification assays for CMV.  Congratulations to all involved with this project!